GROUP ONE TRADING LLC - THERAVANCE BIOPHARMA INC ownership

THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 116 filers reported holding THERAVANCE BIOPHARMA INC in Q1 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.4%.

Quarter-by-quarter ownership
GROUP ONE TRADING LLC ownership history of THERAVANCE BIOPHARMA INC
ValueSharesWeighting
Q2 2023$31,764
-18.9%
3,069
-15.0%
0.00%
Q1 2023$39,190
+5.9%
3,612
+0.1%
0.00%
Q3 2022$37,000
+146.7%
3,608
+115.4%
0.00%
Q2 2022$15,000
-81.9%
1,675
-80.7%
0.00%
Q1 2022$83,000
-83.3%
8,675
-80.7%
0.00%
Q4 2021$497,000
+3.3%
45,005
-30.8%
0.00%
-100.0%
Q3 2021$481,000
+2906.2%
65,058
+10113.2%
0.00%
Q4 2019$16,000
-95.1%
637
-96.2%
0.00%
-100.0%
Q3 2019$326,000
-66.5%
16,737
-71.9%
0.00%
-66.7%
Q2 2019$973,000
+271.4%
59,568
+414.5%
0.01%
+200.0%
Q1 2019$262,000
+870.4%
11,577
+952.5%
0.00%
Q1 2018$27,000
-77.5%
1,100
-68.6%
0.00%
-100.0%
Q3 2017$120,000
+140.0%
3,500
+154.2%
0.00%0.0%
Q3 2016$50,000
-9.1%
1,377
-52.7%
0.00%0.0%
Q1 2016$55,000
-5.2%
2,912
-17.1%
0.00%0.0%
Q4 2015$58,000
-88.8%
3,512
-92.6%
0.00%
-85.7%
Q3 2015$520,000
+5100.0%
47,284
+8038.4%
0.01%
Q1 2015$10,000
-79.2%
581
-72.2%
0.00%
-100.0%
Q3 2014$48,000
-57.1%
2,093
-40.6%
0.00%
-50.0%
Q2 2014$112,0003,5210.00%
Other shareholders
THERAVANCE BIOPHARMA INC shareholders Q1 2023
NameSharesValueWeighting ↓
Foundation Asset Management, LP 933,881$13,934,0003.34%
Baupost Group 6,061,228$90,434,0001.78%
Clearline Capital LP 250,550$3,738,0000.58%
Rock Springs Capital Management LP 290,000$4,327,0000.51%
Roundview Capital LLC 41,917$625,0000.26%
Old West Investment Management, LLC 19,811$295,0000.18%
HighVista Strategies LLC 86,700$1,294,0000.17%
CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD 296,234$4,420,0000.17%
FIRST MANHATTAN CO. LLC. 1,446,960$21,588,0000.12%
REINHART PARTNERS, LLC. 71,850$1,072,0000.08%
View complete list of THERAVANCE BIOPHARMA INC shareholders